Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 226,672 | 106,773 | 65,997 | 71,660 | 169,489 |
| Marketable Securities | 20,213 | 71,455 | 135,222 | 145,366 | 57,083 |
| Receivables | 6,370 | 246 | 2,918 | 3,582 | 4,012 |
| Inventories | 15 | N/A | N/A | N/A | N/A |
| TOTAL | $259,277 | $183,476 | $208,646 | $225,375 | $234,078 |
| Non-Current Assets | |||||
| PPE Net | 1,614 | 1,541 | 1,193 | 957 | 951 |
| Investments And Advances | 210 | 322 | 306 | 371 | 157 |
| Intangibles | 3,967 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,264 | 3,588 | 1,069 | 1,160 | 1,279 |
| TOTAL | $9,055 | $5,451 | $2,568 | $2,488 | $2,387 |
| Total Assets | $268,332 | $188,927 | $211,214 | $227,863 | $236,465 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,351 | 9,459 | 9,049 | 9,910 | 10,181 |
| TOTAL | $23,249 | $14,765 | $13,255 | $15,429 | $14,273 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,708 | 24,607 | 24,515 | 19,434 | 19,356 |
| Other Non-Current Liabilities | 1,711 | 1,826 | 40 | 100 | 209 |
| TOTAL | $31,419 | $26,433 | $24,555 | $19,534 | $19,565 |
| Total Liabilities | $54,668 | $41,198 | $37,810 | $34,963 | $33,838 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,105 | 32,617 | 26,804 | 26,732 | 26,672 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -202,754 | -163,606 | -132,182 | -108,763 | -95,164 |
| Other shareholders' equity | -8 | -23 | -70 | -74 | -10 |
| TOTAL | $213,664 | $147,729 | $173,404 | $192,900 | $202,627 |
| Total Liabilities And Equity | $268,332 | $188,927 | $211,214 | $227,863 | $236,465 |